TABLE 1.

Patient Demographics and Clinical Characteristics

Characteristic	Data
Total patients (n)	219
Mean age (y)	68 (range, 46–87)
Median PSA (ng/mL)	8.0 (range, 0.2–9,708)
Disease stage at time of 18F-NaF PET/CT (n)
Staging	129
Biochemical recurrence	67
mCRPC	23
Gleason score (n)
<7	17 (8%)
7	121 (55%)
8	31 (14%)
9	38 (17%)
10	2 (1.0%)
Unknown	10 (5%)
T-stage (n)
T1	66 (30%)
T2	86 (39%)
T3	49 (22%)
T4	11 (5%)
Unknown	7 (4%)

PSA = prostate-specific antigen; mCRPC = metastatic castration-resistant PCa.